Similar articles for PMID: 10811508

Year	Number of Results
1996	3
1997	3
1998	6
1999	13
2000	19
2001	41
2002	40
2003	43
2004	28
2005	22
2006	22
2007	20
2008	18
2009	16
2010	19
2011	21
2012	16
2013	4
2014	7
2015	6
2016	4
2017	6
2018	4
2019	2
2020	1
2021	2
2022	2
2023	1
2024	0

1

Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).

Frasci G, Comella P, D'Aiuto G, Thomas R, Capasso I, Elmo M, Botti G, Cortino GR, Lapenta L, De Rosa V, Vallone P, Petrillo A, Comella G. Frasci G, et al. Ann Oncol. 2000 Mar;11(3):367-71. doi: 10.1023/a:1008346708604. Ann Oncol. 2000. PMID: 10811508 Free article. Clinical Trial.

2

Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.

Hainsworth JD, Burris HA 3rd, Billings FT 3rd, Bradof JE, Baker M, Greco FA. Hainsworth JD, et al. Cancer. 2001 Nov 1;92(9):2391-8. doi: 10.1002/1097-0142(20011101)92:9<2391::aid-cncr1587>3.0.co;2-m. Cancer. 2001. PMID: 11745295 Clinical Trial.

3

Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.

Brugnatelli S, Danova M, De Bella MT, Vaglica M, Manuguerra G, Riccardi A, Palmeri S. Brugnatelli S, et al. Oncology. 2002;62(1):33-8. doi: 10.1159/000048244. Oncology. 2002. PMID: 11810041 Clinical Trial.

4

An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.

Pectasides D, Kalofonos HP, Samantas E, Nicolaides C, Papacostas P, Onyenadum A, Visvikis A, Skarlos D, Fountzilas G. Pectasides D, et al. Anticancer Res. 2001 Jul-Aug;21(4B):3005-10. Anticancer Res. 2001. PMID: 11712802 Clinical Trial.

5

Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer.

Campone M, Fumoleau P, Delecroix V, Deporte-Fety R, Perrocheau G, Vernillet L, Borg-Olivier O, Louboutin JP, Bissery MC, Riva A, Azli N. Campone M, et al. Ann Oncol. 2001 Jul;12(7):909-18. doi: 10.1023/a:1011133410652. Ann Oncol. 2001. PMID: 11521794 Free article. Clinical Trial.

6

Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines.

Martí JL, Bueso P, Mayordomo JI, Isla MD, Saenz A, Escudero P, Murillo L, Filipovich E, Andres R, Tres A. Martí JL, et al. Ann Oncol. 2001 Aug;12(8):1061-5. doi: 10.1023/a:1011691307995. Ann Oncol. 2001. PMID: 11583186 Free article.

7

The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.

Morabito A, Filippelli G, Palmeri S, Cascinu S, Ferraù F, Zagonel V, Gattuso D, Catalano V, Capaccetti B, Franciosi V, Accurso V, Scinto F, Gasparini G. Morabito A, et al. Breast Cancer Res Treat. 2003 Mar;78(1):29-36. doi: 10.1023/a:1022197109592. Breast Cancer Res Treat. 2003. PMID: 12611454 Clinical Trial.

8

Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer.

Bhargava P, Marshall JL, Fried K, Williams M, Lefebvre P, Dahut W, Hanfelt J, Gehan E, Figuera M, Hawkins MJ, Rizvi NA. Bhargava P, et al. Cancer Chemother Pharmacol. 2001 Aug;48(2):95-103. doi: 10.1007/s002800100317. Cancer Chemother Pharmacol. 2001. PMID: 11561784 Clinical Trial.

9

Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study.

Riccardi A, Brugnatelli S, Danova M, Giordano M, Pugliese P, Luchena G, Grasso D, Trotti G, Bertè R, Pansini G, Tinelli C. Riccardi A, et al. Tumori. 2006 Jan-Feb;92(1):6-12. doi: 10.1177/030089160609200102. Tumori. 2006. PMID: 16683377 Clinical Trial.

10

Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.

Medioni J, Huchon C, Le Frere-Belda MA, Hofmann H, Bats AS, Eme D, Andrieu JM, Oudard S, Lecuru F, Levy E. Medioni J, et al. Drugs R D. 2011;11(2):147-57. doi: 10.2165/11591210-000000000-00000. Drugs R D. 2011. PMID: 21679005 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

360 results

Results by year